These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 20124470)
1. Deregulated E2F and the AAA+ coregulator ANCCA drive proto-oncogene ACTR/AIB1 overexpression in breast cancer. Hsia EY; Kalashnikova EV; Revenko AS; Zou JX; Borowsky AD; Chen HW Mol Cancer Res; 2010 Feb; 8(2):183-93. PubMed ID: 20124470 [TBL] [Abstract][Full Text] [Related]
2. Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark. Revenko AS; Kalashnikova EV; Gemo AT; Zou JX; Chen HW Mol Cell Biol; 2010 Nov; 30(22):5260-72. PubMed ID: 20855524 [TBL] [Abstract][Full Text] [Related]
3. Proto-oncogene ACTR/AIB1 promotes cancer cell invasion by up-regulating specific matrix metalloproteinase expression. Li LB; Louie MC; Chen HW; Zou JX Cancer Lett; 2008 Mar; 261(1):64-73. PubMed ID: 18162290 [TBL] [Abstract][Full Text] [Related]
4. The roles and action mechanisms of p160/SRC coactivators and the ANCCA coregulator in cancer. Hsia EY; Zou JX; Chen HW Prog Mol Biol Transl Sci; 2009; 87():261-98. PubMed ID: 20374707 [TBL] [Abstract][Full Text] [Related]
5. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors. Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753 [TBL] [Abstract][Full Text] [Related]
6. ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Louie MC; Zou JX; Rabinovich A; Chen HW Mol Cell Biol; 2004 Jun; 24(12):5157-71. PubMed ID: 15169882 [TBL] [Abstract][Full Text] [Related]
7. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M. Polzin RG; Benlhabib H; Trepel J; Herrera JE Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303 [TBL] [Abstract][Full Text] [Related]
8. Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma. Heck S; Rom J; Thewes V; Becker N; Blume B; Sinn HP; Deuschle U; Sohn C; Schneeweiss A; Lichter P Cancer Res; 2009 Jun; 69(12):5186-93. PubMed ID: 19491275 [TBL] [Abstract][Full Text] [Related]
9. ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes. Zou JX; Zhong Z; Shi XB; Tepper CG; deVere White RW; Kung HJ; Chen H Prostate; 2006 Oct; 66(14):1474-86. PubMed ID: 16921507 [TBL] [Abstract][Full Text] [Related]
10. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2. Kalashnikova EV; Revenko AS; Gemo AT; Andrews NP; Tepper CG; Zou JX; Cardiff RD; Borowsky AD; Chen HW Cancer Res; 2010 Nov; 70(22):9402-12. PubMed ID: 20864510 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1. Zhou D; Masri S; Ye JJ; Chen S Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749 [TBL] [Abstract][Full Text] [Related]
12. Direct control of cell cycle gene expression by proto-oncogene product ACTR, and its autoregulation underlies its transforming activity. Louie MC; Revenko AS; Zou JX; Yao J; Chen HW Mol Cell Biol; 2006 May; 26(10):3810-23. PubMed ID: 16648476 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of transcriptional repression of gelsolin in human breast cancer cells. Dong Y; Asch HL; Ying A; Asch BB Exp Cell Res; 2002 Jun; 276(2):328-36. PubMed ID: 12027462 [TBL] [Abstract][Full Text] [Related]
14. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer. Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053 [TBL] [Abstract][Full Text] [Related]
15. ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification. Zou JX; Revenko AS; Li LB; Gemo AT; Chen HW Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18067-72. PubMed ID: 17998543 [TBL] [Abstract][Full Text] [Related]
16. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis. Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J Cancer Res; 2005 Sep; 65(17):7993-8002. PubMed ID: 16140972 [TBL] [Abstract][Full Text] [Related]
17. Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy. Eelen G; Vanden Bempt I; Verlinden L; Drijkoningen M; Smeets A; Neven P; Christiaens MR; Marchal K; Bouillon R; Verstuyf A Oncogene; 2008 Jul; 27(30):4233-41. PubMed ID: 18345034 [TBL] [Abstract][Full Text] [Related]
18. Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance. Zou JX; Duan Z; Wang J; Sokolov A; Xu J; Chen CZ; Li JJ; Chen HW Mol Cancer Res; 2014 Apr; 12(4):539-49. PubMed ID: 24391143 [TBL] [Abstract][Full Text] [Related]
19. [Expression of AIB1 protein in gynecological tumors]. Han XY; Zhang XM; Chen Y; Yang KX; Qie MR Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):246-9. PubMed ID: 17441340 [TBL] [Abstract][Full Text] [Related]
20. 17beta-estradiol (E2) induces cdc25A gene expression in breast cancer cells by genomic and non-genomic pathways. Ru Lee W; Chen CC; Liu S; Safe S J Cell Biochem; 2006 Sep; 99(1):209-20. PubMed ID: 16598773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]